LU84314A1 - Procede de preparation de derives d'esters internes de gangliosides et compositions pharmaceutiques contenant ces derives - Google Patents

Procede de preparation de derives d'esters internes de gangliosides et compositions pharmaceutiques contenant ces derives Download PDF

Info

Publication number
LU84314A1
LU84314A1 LU84314A LU84314A LU84314A1 LU 84314 A1 LU84314 A1 LU 84314A1 LU 84314 A LU84314 A LU 84314A LU 84314 A LU84314 A LU 84314A LU 84314 A1 LU84314 A1 LU 84314A1
Authority
LU
Luxembourg
Prior art keywords
residue
nana
gai
glc
galnac
Prior art date
Application number
LU84314A
Other languages
English (en)
French (fr)
Inventor
Valle Francesco Della
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of LU84314A1 publication Critical patent/LU84314A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
LU84314A 1981-08-04 1982-08-03 Procede de preparation de derives d'esters internes de gangliosides et compositions pharmaceutiques contenant ces derives LU84314A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/290,106 US4476119A (en) 1981-08-04 1981-08-04 Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US29010681 1981-08-04

Publications (1)

Publication Number Publication Date
LU84314A1 true LU84314A1 (fr) 1983-02-28

Family

ID=23114556

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84314A LU84314A1 (fr) 1981-08-04 1982-08-03 Procede de preparation de derives d'esters internes de gangliosides et compositions pharmaceutiques contenant ces derives

Country Status (30)

Country Link
US (1) US4476119A (no)
EP (1) EP0072722B1 (no)
JP (2) JPS5829796A (no)
KR (1) KR860000274B1 (no)
AR (1) AR229853A1 (no)
AT (1) ATE20238T1 (no)
AU (1) AU552609B2 (no)
BE (1) BE894024A (no)
CA (1) CA1230596A (no)
CH (1) CH663617A5 (no)
DE (1) DE3271547D1 (no)
DK (1) DK151967C (no)
ES (1) ES8403925A1 (no)
FI (1) FI72522C (no)
FR (1) FR2511005B1 (no)
GR (1) GR77228B (no)
HK (1) HK86987A (no)
HU (1) HU193151B (no)
IE (1) IE53432B1 (no)
IL (1) IL66457A0 (no)
IN (2) IN156247B (no)
IT (1) IT1217327B (no)
LU (1) LU84314A1 (no)
NO (1) NO160518C (no)
NZ (1) NZ201440A (no)
PL (1) PL143207B1 (no)
PT (1) PT75369B (no)
SG (1) SG57887G (no)
YU (1) YU168882A (no)
ZA (1) ZA825586B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4593091A (en) * 1981-08-04 1986-06-03 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
US4868161A (en) * 1984-06-29 1989-09-19 City Of Hope Method for promoting nerve regeneration
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
US4762822A (en) * 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
US4769362A (en) * 1985-10-01 1988-09-06 Trustees Of Boston University Increased vascular perfusion following administration of lipids
US4710490A (en) * 1985-10-01 1987-12-01 Angio Medical Corporation Compositions containing ganglioside molecules with enhanced angiogenic activity
US4673667A (en) * 1985-10-31 1987-06-16 Trustees Of Boston University Lipids with plasmin inhibitory properties
US4766111A (en) * 1985-10-31 1988-08-23 Trustees Of Boston University Lipids with plasmin inhibitory properties
US4767746A (en) * 1985-12-04 1988-08-30 Trustees Of Boston University Method for enhancement of healing of epithelial wounds in mammals
US4778787A (en) * 1985-12-20 1988-10-18 Trustees Of Boston University Method for treatment of angina and myocardial infarctions with omental lipids
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
FR2614306B1 (fr) * 1987-04-22 1989-07-28 Pf Medicament Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US6407072B1 (en) 1988-12-02 2002-06-18 Fidia S.P.A. Lysoganglioside derivatives
IT1232175B (it) * 1989-07-27 1992-01-25 Fidia Farmaceutici Analoghi semisintetici di gangliosidi
IT1232176B (it) 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
US5212075A (en) * 1991-04-15 1993-05-18 The Regents Of The University Of California Compositions and methods for introducing effectors to pathogens and cells
IT1251991B (it) * 1991-11-08 1995-05-27 Fidia Spa Impiego di gangliosidi per la preparazione di composizioni farmaceutiche attive nella prevenzione di disfunzioni associate all'abuso di cocaina e psicostimolanti ad essa collegati
IT1258310B (it) * 1992-04-10 1996-02-22 Fidia Spa Composizioni farmaceutiche comprendenti derivati monosialogangliosidici atte al trattamento del danno al midollo spinale.
IT1302530B1 (it) * 1998-12-16 2000-09-05 Fidia Spa In Amministrazione S Processo di preparazione del ganglioside gm3 e dei suoi lisoderivati apartire dal ganglioside gm1.
AU2002326805B2 (en) 2001-08-29 2009-01-22 Seneb Biosciences, Inc. Novel synthetic ganglioside derivatives and compositions thereof
NZ542148A (en) 2003-03-06 2008-05-30 Neose Technologies Inc Methods and compositions for the enzymatic synthesis of gangliosides
JP4005115B1 (ja) * 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease
CN108498523B (zh) * 2017-02-24 2023-06-20 上海交通大学 含不饱和脂肪酸链的神经节苷脂衍生物的制备方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207414A (en) * 1978-08-16 1980-06-10 President And Fellows Of Harvard College Polysaccharide antigens
IE51174B1 (en) * 1980-04-14 1986-10-29 Merck & Co Inc Group b streptococcal capsular polysaccharides

Also Published As

Publication number Publication date
FI822673L (fi) 1983-02-05
FR2511005A1 (fr) 1983-02-11
PT75369B (en) 1984-12-10
AU552609B2 (en) 1986-06-12
FI822673A0 (fi) 1982-07-30
IT1217327B (it) 1990-03-22
EP0072722A2 (en) 1983-02-23
HU193151B (en) 1987-08-28
IE821862L (en) 1983-02-04
IL66457A0 (en) 1982-12-31
HK86987A (en) 1987-11-27
JPS5829796A (ja) 1983-02-22
PT75369A (en) 1982-09-01
DK346382A (da) 1983-02-05
IE53432B1 (en) 1988-11-09
KR860000274B1 (ko) 1986-03-26
BE894024A (fr) 1983-02-03
CH663617A5 (fr) 1987-12-31
KR840000905A (ko) 1984-03-26
YU168882A (en) 1985-06-30
NO160518B (no) 1989-01-16
NO822648L (no) 1983-02-07
ATE20238T1 (de) 1986-06-15
FR2511005B1 (fr) 1989-02-24
EP0072722B1 (en) 1986-06-04
FI72522B (fi) 1987-02-27
DK151967B (da) 1988-01-18
JPH01308292A (ja) 1989-12-12
DE3271547D1 (en) 1986-07-10
CA1230596A (en) 1987-12-22
PL237770A1 (en) 1983-03-28
NO160518C (no) 1989-04-26
US4476119A (en) 1984-10-09
FI72522C (fi) 1987-06-08
PL143207B1 (en) 1988-01-30
GR77228B (no) 1984-09-11
EP0072722A3 (en) 1983-05-11
JPH032874B2 (no) 1991-01-17
DK151967C (da) 1988-06-20
ZA825586B (en) 1983-07-27
ES514684A0 (es) 1984-04-01
JPH0211569B2 (no) 1990-03-14
SG57887G (en) 1987-09-18
IN156298B (no) 1985-06-15
AU8672782A (en) 1983-02-10
NZ201440A (en) 1985-11-08
IT8248898A0 (it) 1982-07-28
ES8403925A1 (es) 1984-04-01
AR229853A1 (es) 1983-12-30
IN156247B (no) 1985-06-08

Similar Documents

Publication Publication Date Title
LU84314A1 (fr) Procede de preparation de derives d'esters internes de gangliosides et compositions pharmaceutiques contenant ces derives
CH670645A5 (no)
FR2722199A1 (fr) Derives de l'acide valproique et leurs applications comme medicaments
WO1989002895A1 (fr) Esters de l'acide n-butyrique et leur utilisation comme medicaments
CH662278A5 (fr) Kit pour l'administration de gangliosides et de leurs derives par inhalation et compositions pharmaceutiques appropriees.
LU85973A1 (fr) Utilisation therapeutique de gm1 dans des pathologies cerebrales severes dues a une ischemie
WO2018162617A1 (fr) AceFaPC POUR LE TRAITEMENT DES MALADIES ACÉTYLCHOLINE DÉPENDANTES
JPH01157995A (ja) 鎮痛−抗炎症活性を有するガングリオシドの内部エステル
WO2019213333A1 (en) Combination therapies with edaravone and prodrugs of edaravone that are orally bioavailable and have altered pharmacokinetic properties
WO2019213335A1 (en) Orally bioavailable prodrugs of edaravone with altered pharmacokinetic properties and methods of use thereof
EP2464667A2 (fr) OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE
KR970005346B1 (ko) 사카라이드 유도체
EP0428440A1 (fr) Nouveaux dérivés solubles et non toxiques des macrolides polyéniques basiques, leur préparation et leurs applications
JPH11514992A (ja) 変性エーテルグリセログリコ脂質
JPH02200697A (ja) リゾガングリオシド誘導体
WO2019052529A1 (zh) 糖类化合物的医药用途
CA2771055C (fr) Oligosaccharides n-sulfates activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
FR2807043A1 (fr) Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
HU208834B (en) Process for producing dilysoganglioside derivatives and pharmaceutical compositions comprising such active ingredient
FR2801055A1 (fr) Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
FR2473887A1 (fr) Nouvelle utilisation des precurseurs biochimiques des glucosamino-glycanes et compositions pharmaceutiques et cosmetiques respectives
EP0240392B1 (fr) Composés du type cyclophosphazène, procédé de préparation et composition pharmaceutique les contenant
FR2664813A1 (fr) Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.